Skip to main content

3 Cannabis Stocks To Bet On For The Coming Cannabis Rush

Microcapspeculators.com is an informational website that is highly interested in exploring development stage companies, enroute to finding companies with the best potential

HENDERSON, NV / ACCESSWIRE / July 17, 2018 / Recreational cannabis is now selling legally in California and Canada, which opened its national marijuana market this month. The estimated $12B sales projection in North America translates to big opportunities for entrepreneurs and brands. In the U.S. the recent and continued success of states like Colorado, Nevada and Washington's cannabis markets along with the lack of federal interference, has helped bring the idea of working with marijuana into the mainstream.

When it comes to recreational marijuana individuals are enjoying cannabis in all kinds of new ways. Most people don't want to smoke anymore for a variety of reasons including lung safety concerns, smell and odor issues, second hand smoke around children and other non smokers, along with the extra time it takes to smoke. There's a huge boom in alternative forms of ingestion. Alternative forms include every kind of edible imaginable (candies, cookies, butters, cooking oils), drinks, topicals, tinctures, lotions and rubs. The legal recreational marijuana industry is revolutionizing business and society in North America.

These three stocks could benefit tremendously from the coming cannabis rush this fall: Nightfood Hldgs Inc. (NGTF), GW Pharmaceuticals Plc. (NASDAQ: GWPH), The Green Organic Dutchman Holdings Ltd. (TGODF)

Nightfood Hldgs Inc. (NGTF)

Market Cap: $15.28M, current share price: $.36

NightFood manufactures and distributes better-for-you snacks specifically formulated to satisfy unhealthy nighttime cravings in a better, healthier, more sleep-friendly way. Future product line extensions may include formats such as NightFood cookies, NightFood ice cream, NightFood bites, and more. In addition, MJ Munchies, Inc. was recently formed as a new, wholly owned subsidiary, to exploit legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the Half-Baked™ brand name. As the legal landscape around CBD and cannabis related products continues to change and evolve, MJ Munchies will continue to explore, identify, and capitalize on opportunities clearly defined as legal. The Company believes tremendous opportunities currently exist to launch successful and compliant products in this space, and that such opportunities will continue to grow over time.

GW Pharmaceuticals Plc. (NASDAQ: GWPH)

Market Cap: $4.26B, current share price: $151.15

GW Pharmaceuticals plc, is a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Its lead product is Epidiolex, an oral medicine which is in Phase III clinical development for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates, which are in Phase I and II clinical development for the treatment of glioma, neonatal hypoxic-ischemic encephalopathy, adult epilepsy, and schizophrenia.

The Green Organic Dutchman Holdings Ltd. (TGODF)

Market Cap: $1.01B, current share price: $4.45

The Green Organic Dutchman Holdings Ltd., through its subsidiary, The Green Organic Dutchman Ltd., operates as a cannabinoid-based research and development company in Canada. It produces organic cannabis products, including organic dried cannabis, cannabis oils and edibles, fresh cannabis, and seeds for medical applications.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and twenty-five thousand total by Regal Consulting, LLC, for NGTF. NGTF and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article's distribution.

For Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators

Contact Person: Media Manager

Email: info@microcapspecualtors.com

Phone: 1-702-720-6310

Country: United States

Website: http://microcapspeculators.com/

SOURCE: ACR Communication, LLC

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.